Frontotemporal dementias: clinical features and management.
This 2-part review of the frontotemporal lobar degeneration (FTLD) begins with an outline of clinical features, which differentiate FTLD from Alzheimer's disease, the more common cause of dementia. The second part describes interventions for FTLD. Although there is currently no disease-modifying therapeutic agent, symptomatic pharmacotherapy helps to control the marked mood and behavioral disturbances that may distinguish this syndrome from other causes of dementia.
Chow
Tiffany W
TW
Department of Neurology, University of Southern California, Downey, CA, USA. tchow@usc.edu
D000368:Aged; D000544:Alzheimer Disease / Q000175:diagnosis / Q000188:drug therapy / Q000523:psychology; D002540:Cerebral Cortex / Q000473:pathology; D003704:Dementia / Q000175:diagnosis* / Q000188:drug therapy / Q000523:psychology; D003937:Diagnosis, Differential; D003952:Diagnostic Imaging; D018450:Disease Progression; D016316:Guanfacine / Q000627:therapeutic use; D006801:Humans; D009415:Nerve Net / Q000473:pathology; D009483:Neuropsychological Tests; D011619:Psychotropic Drugs / Q000627:therapeutic use
D011619:Psychotropic Drugs; D016316:Guanfacine